1/19/17: Welcoming new Board Member, Andrew Freedman, PhD

Dr. Freedman is the Clinical and Translational Epidemiology Branch Chief of the Epidemiology and Genomics Research Program, part of the Division of Cancer Control and Population Sciences at the National Cancer Institute of NIH. We are happy to have him on our Board and look forward to his valuable input as we start profiling genetic databases and biobanks this year.